Clinical characteristics of juvenile systemic sclerosis in Japanese [2]

Journal of Rheumatology

Volumn 32, Issue 9, 2005, Pages 1850-1852

  Murata, Maki ^a   Sato, Shinichi ^a,b   Komura, Kazuhiro ^a   Hasegawa, Minoru ^a   Takehara, Kazuhiko ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE; ENZYME ANTIBODY; PREDNISOLONE;

ADOLESCENT; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HOSPITAL ADMISSION; HUMAN; LETTER; LUNG FIBROSIS; MALE; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCHOOL CHILD; SCLERODERMA; SYMPTOM; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE OF ONSET; BIOPSY, NEEDLE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFANT; JAPAN; MALE; PREDNISOLONE; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 24944551960     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (13)

1. Vancheeswaran R, Black CM, David J, et al. Childhood-onset scleroderma: is it different from adult-onset disease. Arthritis Rheum 1996;39;1041-9.
2. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
3. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
4. Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988;31:196-203.
5. Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Elevated circulating CD40L concentrations in patients with systemic sclerosis. J Rheumatol 2004;31:514-9.
6. Kass H, Hanson V, Patrick J. Scleroderma in childhood. J Pediatr 1966;68:243-56.
7. Suarez-Almazor ME, Catoggio LJ, Maldonado-Cocco JA, Cuttica R, Garcia-Morteo O. Juvenile progressive systemic sclerosis: clinical and serologic findings. Arthritis Rheum 1985;28:699-702.
8. Martinez-Cordero E, Fonseca MC, Aquilar Leon DE, Padilla A. Juvenile systemic sclerosis. J Rheumatol 1993;20:405-7.
9. Kornreich HK, King KK, Bernstein BH, Singsen BH, Hanson V. Scleroderma in childhood. Arthritis Rheum 1977;20:343-50.
10. Vesely R, Vargova V, Ravelli A, et al. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis. J Rheumatol 2004;31:795-800.
11. Foeldvari I, Zhavania M, Birdi N, et al. Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey. Rheumatology Oxford 2000;39:556-9.
12. Lababidi HM, Nasr FW, Khatib Z. Juvenile progressive systemic sclerosis: report of five cases. J Rheumatol 1991;18:885-8.
13. Cassidy JT, Sullivan DB, Dabich L, Petty RE. Scleroderma in children. Arthritis Rheum 1977;20:351-4.